Association of catechol-O-methyltransferase Val158Met polymorphism with fibromyalgia risk and FIQ scores: an updated meta-analysis

To investigate associations of catechol-O-methyltransferase (COMT) Val158Met polymorphism with susceptibility to fibromyalgia and Fibromyalgia Impact Questionnaire (FIQ) score in patients with fibromyalgia (FM). A comprehensive search was carried out across the Medline, Embase, and Web of Science da...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental rheumatology Jg. 43; H. 6; S. 1002
Hauptverfasser: Lee, Young Ho, Song, Gwan Gyu
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Italy 01.06.2025
Schlagworte:
Catechol O-Methyltransferase - genetics
Chi-Square Distribution
Female
Fibromyalgia - diagnosis
Fibromyalgia - enzymology
Fibromyalgia - ethnology
Fibromyalgia - genetics
Fibromyalgia - physiopathology
Fibromyalgia - psychology
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Odds Ratio
Phenotype
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Risk Factors
Surveys and Questionnaires
ISSN:0392-856X
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To investigate associations of catechol-O-methyltransferase (COMT) Val158Met polymorphism with susceptibility to fibromyalgia and Fibromyalgia Impact Questionnaire (FIQ) score in patients with fibromyalgia (FM). A comprehensive search was carried out across the Medline, Embase, and Web of Science databases to identify pertinent articles. A meta-analysis was then conducted to evaluate the relationship between the COMT Val158Met polymorphism and both the risk of developing FM and the Fibromyalgia Impact Questionnaire (FIQ) score. The meta-analysis included 2,115 patients and 1,867 controls from 16 studies on COMT Val158Met polymorphism and 1,199 patients from eight studies on COMT Val158Met polymorphism and FIQ score in FM. Findings revealed an association between FM and COMT Met allele across all study subjects (OR: 1.375, 95% CI: 1.076-1.757, p=0.001). However, regional stratification showed no association between the COMT Met allele and FM in European, Latin American, or Asian populations. The same pattern was observed using recessive, dominant, and homozygote contrast models for the COMT Met allele. Furthermore, the FIQ score was significantly higher in patients with the COMT Met/Met genotype than in those with the Val/Val genotype (WMD: 11.24, 95% CI: 4.742-17.74, p=0.001) and the Val/Met genotype (WMD: 5.950, 95% CI: 2.017-9.893, p=0.003). This meta-analysis indicates significant associations of COMT Val158Met polymorphism with both FM risk and FIQ score in FM patients.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0392-856X
DOI:10.55563/clinexprheumatol/8njnoh